Usher Syndrome – Pipeline Review, H2 2016 – Amgen, Editas Medicine, ProQR Therapeutics NV & Sanofi are Key Companies Profiled – Research and Markets
DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Usher Syndrome - Pipeline Review, H2 2016" report to their offering. Usher syndrome is an inherited condition characterized by hearing impairment and progressive vision loss. The major symptoms of Usher syndrome are hearing loss and an eye disorder called retinitis pigmentosa. Risk factors include retinal degeneration, prolonged, unprotected exposure to sunlight may accelerate vision loss. Treatment includes cochle